Part 4/6:
With the newly developed therapy, the patient's blood cells can be transformed into functioning beta cells, allowing his body to produce insulin again independently. Hence, the patient no longer needs to depend on external insulin, offering the potential for a life free from the shackles of diabetes management.
Implications for China
The implications of this groundbreaking technology are vast, especially in a country like China, which faces a significant public health challenge due to the high prevalence of diabetes. With approximately 140 million individuals diagnosed with diabetes in China, and an alarming 40 million relying on lifelong insulin injections, this new cell therapy presents a transformative solution that could alleviate both personal and societal burdens.